Quantcast

Tag Archives: pharmaceutical

Baltimore biotech Gliknik, Pfizer sign accord

Gliknik Inc., of Baltimore, a biotech that develops novel molecular treatments for autoimmune/inflammatory diseases and cancer, said it has entered into an exclusive worldwide licensing agreement with drug-making giant Pfizer Inc. for its pharmaceutical candidate, GL-2045, a potential treatment for a variety of autoimmune diseases.

Read More »

Maryland mergers and acquisitions surge in 1Q

Bucking a national trend, Maryland mergers and acquisitions rose almost 25 percent in the first quarter of 2012 compared with the last quarter of 2011, with the increase largely driven by the biotechnology, pharmaceutical and medical sector. According to data ...

Read More »